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Background: Traditional systems of medicine use herbal drugs for hepatoprotection. Thus,
the  study was designed to evaluate the hepatoprotective and antioxidant effects of Spondias
pinnata bark extracts against ethanol-induced liver injury in Wistar rats.
Methods: Group I animals were treated with 1 mL/kg 0.3% carboxymethyl cellulose and Group
II  with 12 mL/kg 50% ethanol for 8 consecutive days. Groups III–VII animals were ﬁrst treated
with  400 mg/kg petroleum ether extract, chloroform extract, acetone extract (AE), ethanol
extract (EE), and 100 mg/kg silymarin, and then 12 mL/kg 50% ethanol orally after 2 hours
pretreatment each day for 8 consecutive days. Six hours after the last dose, blood was with-
drawn. The hepatoprotective activity was assessed by several biochemical and antioxidant
parameters. It was accomplished by the histopathology and DNA fragmentation study of
liver tissues.
Results: Treatment with S. pinnata extracts, mainly AE and EE signiﬁcantly (p < 0.05–0.01)
and  dose-dependently prevented the ethanol-induced increase in serum levels of aspartate
aminotransferase, alanine aminotransferase, alkaline phosphatase, lactate dehydrogenase,
cholesterol, bilirubin, and malondialdehyde, and decrease in reduced glutathione, catalase,
superoxide dismutase, and albumin. They also attenuated the ethanol-induced DNA dam-
age.  Hepatoprotective potential of the extract was less than that of standard drug silymarin.
Results of the study were well supported by the histopathological observations.
Conclusion: S. pinnata extracts AE and EE possess a potent hepatoprotective effect againstethanol-induced liver injury in Wistar rats, and protect them from hepatotoxicity by pre-
vention of ethanol-induced oxidative stress, DNA-damage and altered biochemical markers.
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1.  Introduction
Alcohol has been the most frequently abused drug for cen-
turies and is the third most common cause of death after
smoking and hypertension, but it was not until the 1960s that
it was recognized as a direct hepatotoxin.1 Liver-related mor-
tality due to alcohol contributes to 4% of mortality and 5% of
disability-adjusted life globally, with highest impact in Europe,
where these same ﬁgures are 7% and 12%, respectively.1 Long-
term excess alcohol exposure leads to a global health problem
of fatty liver and alcoholic liver diseases without effective ther-
apeutic approaches.2
Spondias pinnata (family: Anacardiaceae), commonly known
as Bile tree or Hog plum and Amrata in Ayurveda, is an
evergreen to deciduous tree that is distributed throughout
India, Sri Lanka, Burma, China (South, Hainan), Malaysia, and
Thailand.3 The stem bark contains phytoconstituents like
alkaloids, ﬂavonoids, and polyphenols.4 The stem bark con-
tains minerals, ellegitannins, and lignoceric acid glucosides of
-sitosterol.5 Root, bark, leaves, and fruits of the tree are use-
ful and are used in traditional systems of medicines.3,6 The
bark has been used for its diuretic properties in Thailand.7
The bark is used as a refrigerant, antidyssenteric, antidiar-
rheal, antiemetic, antiseptic, tonic, and astringent by different
ethnic communities of India, and the paste or lotion of the
bark extract when rubbed onto the skin provides relief from
sprain and strain in articular and muscular rheumatism.8 Bark
of the tree is known to have hypoglycemic, ulcer-protective,
anti-cancer, cytotoxic, thrombolytic, antipyretic, antimicro-
bial, central nervous system depressant and several other
pharmacological activities.9–12 Stem wood extract of the tree
has been reported to reduce hepatotoxicity induced by car-
bon tetrachloride in experimental rats.13 There is no scientiﬁc
documentation available about the hepatoprotective effect of
S. pinnata bark against ethanol-induced liver injury, which
is clinically relevant. Hence, we attempted to evaluate the
hepatoprotective effect of S. pinnata bark extracts against
ethanol-induced liver injury in Wistar rats.
2.  Methods
2.1.  Chemical  reagents,  drugs,  and  equipment
All the chemicals used were of analytical grade: 0.9% normal
saline (Albert David, India), silymarin (Sigma Chemicals, St
Louis, MO, USA), chloroform (Rankem, India), ethanol (Chang-
shu Yangyuan Chemical, China), petroleum ether (Fisher
Scientiﬁc, India), acetone (Fisher Scientiﬁc), formaldehyde
(Fisher Scientiﬁc), ethyl acetate (Himedia Chemicals, India),
methanol (Fisher Scientiﬁc), diethyl ether (SD Fine Chem-
icals, India), acetic acid (SD Fine Chemicals), formic acid
(Rankem). The equipment was: UV spectrophotometer (Phar-
maSpec UV-1700; Shimadzu, Japan), micropipette (Superﬁt,
India), centrifuge (Spinnwell, India), digital balance (AUX220
Unibloc; Shimadzu), refrigerator (Intello Cool LG, India), and
gel electrophoresis (Gel Doc XR +; Bio-Rad, USA).Integr Med Res ( 2 0 1 6 ) 267–275
2.2.  Collection  and  authentication  of  plant  specimens
S. pinnata bark was obtained from Banaras of Uttar Pradesh
in April and authenticated by the botanists, authen-
tication ofﬁce, Faculty of Pharmacy, Integral University
Lucknow, Lucknow, India. A voucher specimen of S. pinnata
(IU/PHAR/HRB/15/12) was deposited there for further refer-
ence.
2.3.  Preparation  of  plant  extracts  and  evaluation  of
extractive  values
The freshly collected bark was dried in the shade, ground
to coarse powder, evenly packed in a Soxhlet extractor, and
successively extracted by Soxhlet extraction method at a tem-
perature not exceeding 45–55 ◦C, using different solvents in
ascending order of their polarity, namely, petroleum ether,
chloroform, acetone, and ethanol to achieve different crude
extracts. One hundred grams of the powdered material was
used in Soxhlet extraction using 1 L of each solvent. Appear-
ance of colorless solvent in the siphon tube was taken as
the termination of extraction. The different crude extracts
obtained were ﬁltered while hot and concentrated separately
in a rotary evaporator (Buchi Rotavapor-R; Labco, India) under
reduced pressure and controlled temperature to dryness and
the percentage yield was calculated. The petroleum ether
extract (PEE), chloroform extract (CE), acetone extract (AE),
and ethanol extract (EE) were kept in an air tight container
in a refrigerator below 4 ◦C and used for pharmacological
evaluation.14
2.4.  Experimental  animals
Rats (150 ± 20 g) were obtained from the animal house of
the Central Drug Research Institute (CDRI), Lucknow, India.
They were kept in the departmental animal house, Integral
University Lucknow. The animals were housed separately
in polypropylene cages for acclimatization at a tempera-
ture of 23 ± 2 ◦C and relative humidity of 50–60% with a
12-hour light/dark cycle for 1 week before and during the
commencement of the experiment. Animals were kept on
standard pellet diet and provided drinking water ad libitum
throughout the housing period. All the experiments were con-
ducted in accordance with the guidelines of the Committee
for the Purpose of Control and Supervision of Experimen-
tal Animal. Ethical clearance for the project was obtained
from Institutional Animal Ethics Committee of the Faculty of
Pharmacy at the Integral University Lucknow (Approval No.
IU/PHARM/M.PHARM/IAEC/15/10).
2.5.  Experimental  protocol
The animals were randomly divided into seven groups each
consisting of ﬁve rats. Group I served as a normal control
and received 1 mL/kg vehicle (0.3% carboxymethyl cellulose)
throughout the study. Group II served as an acute toxic con-
trol and received 12 mL/kg orally (po) 50% ethanol orally
throughout the study. Groups III–VI received 400 mg/kg po
of different bark extracts of S. pinnata orally, and Group VII
received standard drug silymarin, 100 mg/kg/d po.15 All groups
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f animals were administered 12 mL/kg po of 50% ethanol
fter 2 hours pretreatment each day, except rats in the nor-
al  control group, for 8 consecutive days.16 Six hours after
he last dose, the rats were anesthetized and blood was col-
ected via the retro-orbital plexus followed by heart puncture
nd allowed to clot. The serum was separated by centrifuga-
ion at 3,000 rpm (845.32 g) at 4 ◦C for 20 minutes for analysis
f various biochemical parameters. After withdrawal of blood,
he animals were killed. The hepatoprotective activity was
ssessed by several biochemical and antioxidant parameters.
he isolated liver tissues were washed twice with ice-cold
aline, blotted, dried, and weighed. The relative liver weight
as calculated as the percentage ratio of the liver weight to
he body weight. It was also accomplished by histopatholog-
cal examination. A small portion of the tissue was ﬁxed in
ormalin for DNA fragmentation study by gel electrophoresis.
.6.  Analysis  of  in  vivo  antioxidant  activity
.6.1.  Estimation  of  tissue  reduced  glutathione
etermination of tissue reduced glutathione (GSH) was
ased on the method of Ellman, in which, 5, 5′-dithiobis-(2-
itrobenzoic acid) (DTNB) was reduced by thiol (-SH) group to
orm 1 mol  2-nitro-5-mercaptobenzoic acid anion with intense
ellow color.17 Four hundred and ﬁfty milligrams of liver tis-
ue was homogenized in 7 mL  0.02 M EDTA and then 4 mL
old distilled water was added to it. After mixing well, 1 mL
0% trichloroacetic acid was added and shaken intermittently
or 10 minutes using a Vortex mixer, Bionics Scientiﬁc, India.
fter 10 minutes, the contents were transferred to centrifuge
ubes rinsed in EDTA and centrifuged at 6,000 rpm(3,381.3 g)
or 15 minutes. Following centrifugation, 2 mL  of the super-
atant was mixed with 4 mL  0.4 M Tris buffer (pH 8.9). The
hole solution was mixed well and 0.1 mL  0.01 M DTNB was
dded to it. The absorbance was read within 5 minutes of the
ddition of DTNB at 412 nm against a reagent blank. The blank
as prepared the same as for the test, except that 0.02 M EDTA
as added in place of tissue homogenate. Tissue GSH was
alculated from the equation:
SH(g/mg protein) = (OD × 50 × 3.5 × 2.25 × 1)/(0.337
×  2 × mg  protein). (1)
here OD is optical density.
.6.2.  Estimation  of  catalase
he decomposition of H2O2 was followed directly by a
ecrease in absorbance at 240 nm.  Liver tissue was homog-
nized in 50 M/mL  potassium phosphate buffer (pH 7.4)
ith a ratio of 1:10 w/v. The homogenate was centrifuged
t 10,000 rpm (9,392.44 g) at 4 ◦C in a cooling centrifuge for
0 minutes. Catalase activity was measured in the super-
atant obtained after centrifugation. Supernatant (0.05 mL)
as added to a cuvette containing 2.95 mL 19 M/mL solu-
ion of H2O2 prepared in potassium phosphate buffer. The
hange in absorbance was monitored at 240 nm wavelength
t 1-minute intervals for 3 minutes. Catalase decomposes
2O2, leading to a decrease in absorbance. The difference
n absorbance (A) per unit time was a measure of catalase269
activity.18 Catalase activity was calculated from the equation:
CAT (molesH2O2consumed/min/mg protein)
= (A/min  × volume of assay)/(0.081
× volume of homogenate × mg  protein). (2)
2.6.3.  Estimation  of  superoxide  dismutase
The supernatant was assayed for superoxide dismutase
(SOD) activity by following the inhibition of pyrogallol auto-
oxidation.19 Cytosolic supernatant (0.01 mL)  was added to Tris
HCl buffer (pH 8.5). The ﬁnal volume of 3 mL  was adjusted
with the same buffer. At least 0.025 mL  24 mM pyrogallol was
added and changes in absorbance at 420 nm were recorded at
1-minute intervals for 3 minutes. The increase in absorbance
at 420 nm after the addition of pyrogallol was inhibited by the
presence of SOD. Data were expressed as SOD units/mg pro-
tein. One unit of SOD was described as the amount of enzyme
required to cause 50% inhibition of pyrogallol auto-oxidation
per 3 mL  of assay mixture and was calculated from the equa-
tion:
Unit of SOD per ml  of sample = [(A − B) × 100]/[A × 50], (3)
where, A is the difference of absorbance in 1 minute in the
control, and B is the difference of absorbance in 1 minute in
the test sample.
2.6.4.  Estimation  of  thiobarbituric  acid  reactive
substances
The dissected liver samples were washed immediately with
ice-cold saline to remove as much blood as possible. Liver was
homogenized in ice-cold 0.9% NaCl with a glass homogenizer
in 5% concentration and the homogenate was centrifuged
at 800 rpm (60.11 g) for 10 minutes. The supernatant was
centrifuged at 12,000 rpm (13,525.12 g) for 15 minutes and
the mitochondrial fraction was used for the estimation of
malondialdehyde (MDA), an end-product of lipid peroxidation
that reacts with thiobarbituric acid (TBA) to form the pink
chromogen TBA reactive substance (TBARS).20 Homogenate
(0.2 mL)was transferred to a vial and mixed with 0.2 mL  8.1%
w/v sodium dodecyl sulfate solution, 1.5 mL 20% acetic acid
solution (adjusted to pH 3.5 with sodium hydroxide) and
1.5 mL  0.8% w/v solution of TBA, and the ﬁnal volume was
adjusted to 4.0 mL  with distilled water. Each vial was tightly
capped and heated in a boiling water bath for 1 hour. The
vials were cooled under running water. Equal volumes of tis-
sue blank or test samples and 10% trichloroacetic acid were
transferred into a centrifuge tube and centrifuged at 1,000 rpm
(93.92 g)for 10 minutes. The absorbance of the supernatant
fraction was measured at 532 nm.  The control experiment
was processed using the same experimental procedure except
that TBA solution was replaced with distilled water. 1,1,3,3-
Tetraethoxypropan was used as standard for calibration of the
curve and was expressed as nmol/mg protein.
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2.7.  Analysis  of  hepatoprotective  activity
Serum alanine aminotransferase (ALT), aspartate amino-
transferase (AST), alkaline phosphatase (ALP), bilirubin, total
cholesterol, albumin, and lactate dehydrogenase (LDH) were
determined as per standard kit methods.
2.7.1.  Estimation  of  ALT
Reagent 2 was added to Reagent 1 in a ratio of 1:4 to prepare
working ALT reagent (ALT test kit, modiﬁed UV-IFCC kinetic
assay; Span Diagnostics, India). One milliliter of ALT reagent
was added to 0.1 mL  serum and mixed. The rate of the oxida-
tion of reduced NADH was measured kinetically by monitoring
the decrease in the absorbance at 340 nm using puriﬁed water
as a blank at an interval of 30 seconds for four successive read-
ings, as per the equation:
ALT activity (mU/mL) = A/ min  ×kinetic factor (4)
where A/min is the change in absorbance per minute and
kinetic factor is 1768.
2.7.2.  Estimation  of  AST
Reagent 2 was added to Reagent 1 in a ratio of 1:4 to prepare
working AST reagent (AST test kit, modiﬁed UV-IFCC kinetic
assay; Span Diagnostics). One milliliter of AST reagent was
added to 0.1 mL  serum and mixed. The rate of oxidation of
NADH was measured kinetically by monitoring the decrease
in the absorbance at 340 nm using puriﬁed water as a blank at
an interval of 30 seconds for four successive readings, as per
the equation:
AST activity (mU/mL) = A/ min  ×kinetic factor (5)
where A/min is the change in absorbance per min  and kinetic
factor is 1768.
2.7.3.  Estimation  of  LDH
Reagent 2 was added to Reagent 1 in a ratio of 1:4 to prepare
working LDH reagent (Inﬁnite liquid LDH, Inﬁnite LDH UV
kinetics assay; Accurex Biomedical, India). One milliliter of
LDH reagent was added to 0.02 mL serum and mixed. The cat-
alytic concentration was determined from the rate of decrease
of NADH+ measured at 340 nm using distilled water as a blank
at an interval of 30 seconds for four successive readings, as per
the equation:
LDH activity(mU/mL) = A/ min  ×kinetic factor (6)
where, A/min is the change in absorbance per min  and
kinetic factor is 8109.
2.7.4.  Estimation  of  ALP
Reagent 2 was added to Reagent 1 in a ratio of 1:4 to prepare
working ALP reagent (ALP test kit, Kinetic assay, Merck Spe-
cialities, India). One milliliter of ALP reagent was added
to 0.02 mL  serum and mixed. In presence of magnesium
ion (Mg2+) and diethanolamine as phosphatase acceptor, p-
nitrophenylphosphate was transformed by ALP to phosphate
and nitrophenol (yellow compound), whose absorbance wasIntegr Med Res ( 2 0 1 6 ) 267–275
measured at 405 nm at an interval of 30 seconds for four suc-
cessive readings, as per the equation:
ALP activity (mU/mL) = A/ min  ×kinetic factor (7)
where, A/min is the change in absorbance per min  and
kinetic factor is 2750.
2.7.5.  Estimation  of  albumin
One milliliter of Reagent 1 was added to 0.01 mL  serum and
to 0.01 mL  standard Reagent 2 (Albumin test kit, modiﬁed
UV-IFCC kinetic assay, Span Diagnostics). It was mixed and
incubated at 37 ◦C for 1 minute. At pH 3.68, albumin acts as a
cation and binds to the anionic dye bromocresol green, form-
ing a green complex whose color intensity is proportional to
albumin concentration in the sample. The absorbance of ﬁnal
color in test and standard mixtures was measured at 630 nm
using a reagent blank as blank, and albumin concentration
was measured, as per the equation:
Albumin (mg/mL) = absorbance of test
× 40/absorbance of standard. (8)
2.7.6.  Estimation  of  cholesterol
One milliliter of Reagent 1 was added to 0.01 mL  serum
and to 0.01 mL  2 mg/mL  standard Reagent 2 (Total choles-
terol test kit, CHOD-PAP; Span Diagnostics). It was mixed
and incubated at 37 ◦C for 10 minutes. Cholesterol esters are
hydrolyzed by cholesterol esterase to yield free cholesterol. In
a subsequent reaction, cholesterol oxidase oxidizes the 3-OH
group of free cholesterol to liberate cholest-4-en-3-one and
H2O2. In the presence of peroxidase, H2O2 couples with 4-
aminoantipyrin and phenol to produce red quinoneimine dye
whose absorbance is measured at 505 nm using Reagent 1 as
a blank. Cholesterol concentration was measured as per the
equation:
cholesterol(mg/mL) = absorbance of test/
(absorbance of standard × 100). (9)
2.7.7.  Estimation  of  total  bilirubin
One milliliter of working reagent was added to 0.1 mL  Reagent
2 for the sample blank and to a mixture of 0.05 mL  each of
Reagent 1 and Reagent 2 for the test sample. Then, 0.05 mL
serum was added to each sample blank and test sample (Biliru-
bin test kit, Jenrassik and Grof; Span Diagnostics). It was
mixed and incubated at room temperature for 5 minutes. The
absorbance of the sample blank and test sample was mea-
sured at 546 nm (1) and 630 nm (2). Sulfanilic acid reacts with
sodium nitrite to produce diazotized sulfanilic acid (diazo).
Total bilirubin couples with diazo and caffeine to produce col-
ored azobilirubin whose intensity is directly proportional to
the amount of total bilirubin present in the sample. The total
bilirubin concentration was measured as per the equation:
Total bilirubin(mg/mL) = (AT1 − AB1) × factor/100 (10)
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here AB1 is the absorbance of sample blank, AT1 is the
bsorbance of test for total bilirubin and kinetic factor is
6.312.
.7.8.  Histopathological  analysis  of  liver  tissues
t the end of each schedule, the control as well as treated
ats were killed under anesthesia after blood withdrawal from
etro-orbital plexus and cardiac puncture. For histopathologi-
al studies, the isolated livers of different groups of rats were
reserved in 10% formalin solution for further examination.
he tissues were mounted by embedding in parafﬁn wax and
-mm slices were cut. The slices were stained by the dyes eosin
nd hematoxylin. The prepared slides were observed under a
ight microscope for visualization of centrilobular necrosis and
ymphocyte inﬁltration.21
.8.  DNA  fragmentation  analysis  of  hepatic  tissues  by
el electrophoresis
ysis buffer was prepared by mixing 50 mL  each of 1 M Tris
Cl and 0.5 M Na-EDTA. The 0.613 mL  lysis buffer was added to
.03 mL  20% sodium lauryl sulfate to form lysis buffer solution,
nd then, 10 mg  homogenized tissue and 0.007 mL  100 g/mL
rotein kinase were added. It was incubated at 55 ◦C for
3 hours in a water bath. The 0.375 mL  of 5 M NaCl was added
nd inverted several times to mix. It was left for 30 minutes
nd centrifuged at 14,000 rpm for 30 minutes at room tem-
erature. Supernatant was carefully transferred to each tube
sing a pipette and then, 0.75 mL chloroform was added to
ach tube. The tubes were inverted several times to mix  and
entrifuged at 12,000 rpm (13,525.12 g) for 10 minutes at room
emperature. The top layer from each tube was transferred.
ibonuclease (0.005 mL)  was added and it was incubated at
7 ◦C for 15 minutes. Isopropanol (0.75 mL)  was added to each
ube and left at 20 ◦C for 30 minutes to precipitate DNA. It was
entrifuged at 14,000 rpm (18409.19 g) for 30 minutes at 4 ◦C
nd the supernatant was drained on tissue paper. The pellets
ere dried under vacuum for 30 minutes. MQ water (0.1 mL)
as added to each tube at room temperature, which were left
or 30 minutes to allow DNA pellets to dissolve.22
The mixture of tris buffer, glacial acetic acid and EDTA
1 L) was prepared by dissolving 48.4 g Tris buffer, 11.4 mL
lacial acetic acid, and 3.7 g Na-EDTA, and then, 1% agarose
el was prepared in 100 mL  TAE. It was boiled for 50 seconds in
 microwave oven and 0.005 mL  ethylene bromide was added
nd shaken for few seconds. It was poured into a mold and
eft for 30 minutes. Then, 50 mL  TAE was poured into the mold.
ow, 0.004 ml  of barium phenol dyes in DNA appendroff’s tube
ere added. Then, micropipette was used and DNA sample
aken and put in well. Current of 50 V was supplied to run
ample. After small run, the current was increased at 100 V
o reach the DNA solution into half mold. The ﬁnal body
eight of the rats of hepatotoxic group II was signiﬁcantly (p <
.01) decreased to 143.4 ± 5.10 g compared to their initial body
eight of 175.6 ± 5.85 g..9.  Statistical  analysis
ne-way analysis of variance followed by Dunnett’s mul-
iple comparison test were performed using Prism version271
3.0 (GraphPad Software, San Diego, CA, USA) for determi-
nation of level of signiﬁcance. The data were expressed as
mean ± standard error and p < 0.05 was considered statistically
signiﬁcant.
3.  Results
3.1.  Evaluation  of  extractive  value
Extractive value for the extracts PEE, CE, AE, and EE was 1.6%
w/w, 1.73% w/w, 4.69% w/w, and 17.2% w/w, respectively.
3.2.  Analysis  of  in  vivo  antioxidant  activity
The effects of different extracts of S. pinnata bark on the
levels of different speciﬁc variables GSH, catalase, SOD, and
TBARS (MDA) in hepatic homogenate in control and exper-
imental groups of animals are presented in Table 1. Oral
50% ethanol (12 mL/kg; hepatotoxic control) signiﬁcantly (p
< 0.01) decreased the levels of hepatic GSH, catalase, and
SOD from 29.8 ± 2.78 g/mg tissue protein, 16.44 ± 1.20 mol
H2O2/mg  tissue protein and 4.85 ± 0.50 U/mg tissue protein
to 18.6 ± 0.812 g/mg tissue protein, 7.74 ± 0.41 mol  H2O2/mg
tissue protein and 2.112 ± 0.33 U/mg tissue protein, respec-
tively, and increased the levels of hepatic MDA from 0.20 ± 0.02
nmol/mg tissue to 0.49 ± 0.02 nmol/mg tissue as compared to
the normal control group rats. Oral EE (400 mg/kg; Group VI)
signiﬁcantly increased the levels of GSH, catalase and SOD
(p < 0.01) to 29.8 ± 1.21 g/mg tissue protein, 13.52 ± 0.50 mol
H2O2/mg  tissue protein and 3.88 ± 0.25 U/mg tissue protein,
respectively, and reduced the level of MDA to 0.27 ± 0.02
nmol/mg tissue as compared to the hepatotoxic control
group rats. The levels of these antioxidant markers GSH,
catalase and SOD were signiﬁcantly (p < 0.01) increased
to 29 ± 1.31 g/mg tissue protein, 14.78 ± 0.70 mol  H2O2/mg
tissue protein, and 4.06 ± 0.28 units/mg tissue protein, respec-
tively, while that of MDA was signiﬁcantly (p < 0.01) reduced to
0.22 ± 0.22 n mole/mg of tissue by treatment with 100 mg/kg
po silymarin (Group VII) as compared to hepatotoxic control
group rats. Treatment with 400 mg/kg po PEE (Group III) and
CE (Group IV) did not signiﬁcantly affect the levels of these
antioxidant markers. Treatment with 400 mg/kg po EE (Group
VI) showed more  protection than 400 mg/kg po PEE (Group III),
CE (Group IV), and AE (Group V) but showed less protection
than 100 mg/kg po silymarin (Group VII).
3.3.  Analysis  of  hepatoprotective  activity
The ﬁnal body weight of hepatotoxic Group II rats following
12 mL/kg po 50% ethanol treatment was signiﬁcantly (p < 0.01)
decreased to 143.4 ± 5.10 g compared to initial body weight of
175.6 ± 5.85 g. Treatment with 400 mg/kg po PEE and CE treat-
ment in Groups III and IV showed non-signiﬁcant increases
in ﬁnal body weight to 158.1 ± 3.43 g and 161.2 ± 5.86 g, respec-
tively, while 400 mg/kg po EE (Group VI) showed a signiﬁcant (p
< 0.01) increase in ﬁnal body weight to 186.1 ± 5.88 g as com-
pared to hepatotoxic Group II rats. Treatment with 12 mL/kg
po 50% ethanol signiﬁcantly (p < 0.01) increased relative
liver weight to 5.81 ± 0.27/100 g body weight compared to the
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Table 1 – Effects of different extracts of Spondias pinnata bark on different liver speciﬁc variables in control and experimental groups of animals
Treatment groups &
liver-speciﬁc
variables
I
Normal control:
0.3% CMC  1 mL/kg
II
Hepatotoxic
control: 50%
ethanol 12 mL/kg
po
III
PEE 400 mg/kg
+ 50% ethanol 12
mL/kg po
IV
CE 400 mg/kg
+ 50% ethanol 12
mL/kg po
V
AE 400 mg/kg
+ 50% ethanol 12
mL/kg po
VI
EE 400 mg/kg
+ 50% ethanol 12
mL/kg po
VII
Silymarin 100
mg/kg + 50%
ethanol 12 mL/kg
po
GSH (g/mg tissue
protein)
29.8  ± 2.78 18.6 ± 0.812* 20 ± 2.53 25 ± 2.60 25.2 ± 2.17 29.8 ± 1.21‡ 29 ± 1.31‡
Catalase (mol H2O2/mg
tissue protein)
16.44 ± 1.20 7.74 ± 0.41* 9.28 ± 0.31 9.40 ± 0.31 10.48 ± 0.52† 13.52 ± 0.50‡ 14.78 ± 0.70‡
SOD (units/mg tissue
protein)
4.85  ± 0.50 2.112 ± 0.33* 2.68 ± 0.18 2.88 ± 0.20 3.64 ± 0.41† 3.88 ± 0.25‡ 4.06 ± 0.28‡
TBARS or MDA (n
mole/mg of tissue)
0.20 ± 0.02 0.49 ± 0.02* 0.50 ± 0.03 0.47 ± 0.02 0.37 ± 0.03† 0.27 ± 0.02‡ 0.22 ± 0.22‡
AST (mU/mL) 89.91 ± 3.21 338.68 ± 8.35* 320.77 ± 8.44 305.76 ± 30.66 275.1 ± 12.10† 123.55 ± 2.49‡ 96.56 ± 2.04‡
ALT (mU/mL) 39.56 ± 0.64 193.53 ± 4.62* 189.93 ± 6.28 176.54 ± 5.04 172.21 ± 8.86† 55.92 ± 1.39‡ 43.53 ± 1.43‡
ALP (mU/mL) 75.99 ± 1.95 209.58 ± 4.33* 190.89 ± 5.31 188.43 ± 10.02 181.37 ± 9.96† 90.04 ± 2.64‡ 81.82 ± 2.75‡
LDH (mU/mL) 381.14 ± 3.37 709.58 ± 5.52* 686.44 ± 5.42 684.42 ± 12.94 655.22 ± 29.89† 405.26 ± 4.95‡ 387.79 ± 5.01‡
Bilirubin (mg/mL) 0.006 ± 0.0002 0.028 ± 0.0008* 0.027 ± 0.0005 0.0257 ± 0.0006 0.0253 ± 0.0006† 0.0087 ± 0.0004‡ 0.0085 ± 0.0002‡
Cholesterol (mg/mL) 0.34 ± 0.01 0.79 ± 0.01* 0.72 ± 0.02 0.73 ± 0.03 0.70 ± 0.03† 0.41 ± 0.01‡ 0.36 ± 0.01‡
Albumin (mg/mL) 40.7 ± 0.1 28.3 ± 0.2* 29.2 ± 0.4 29.4 ± 0.3 29.6 ± 0.6† 43.9 ± 0.1‡ 40.9 ± 0.1‡
Initial BW (g) 166.4 ± 3.48 175.6 ± 5.85 159.8 ± 2.63 162.4 ± 4.21 170.4 ± 3.21 171.4 ± 7.76 161.4 ± 2.08
Final BW (g) 185.1 ± 6.92 143.4 ± 5.10* 158.1 ± 3.43 161.2 ± 5.86 168 ± 5.93† 186.1 ± 5.88‡ 181.8 ± 6.39‡
Liver weight (g) 5.20 ± 0.24 8.67 ± 0.31* 8.58 ± 0.08 8.12 ± 0.25 7.03 ± 0.68† 5.82 ± 0.52‡ 5.42 ± 0.15‡
Relative liver weight
(liver weight/100 g
BW)
2.80 ± 0.04 5.81 ± 0.27* 5.43 ± 0.06 5.03 ± 0.05† 4.14 ± 0.32‡ 3.09 ± 0.18‡ 2.98 ± 0.03‡
Values expressed as mean ± standard error (n = 5).
∗ p < 0.01 as compared with respective normal control Group I.
† p < 0.05 as compared with respective hepatotoxic control Group II.
‡ p < 0.01 as compared with respective hepatotoxic control Group II.
AE, acetone extract; ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate transaminase; BW, body weight; CE, chloroform extract; CMC, carboxymethyl cellulose; EE, ethanol extract;
GSH, reduced glutathione; LDH, lactate dehydrogenase; MDA, malondialdehyde; PEE, petroleum ether extract; SOD, superoxide dismutase; TBARS, thiobarbituric acid reactive substance.
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Fig. 1 – Histopathology of liver tissues under 40 × magniﬁcation: (A) Normal control showing uniform hepatocytes with
small vesicular nuclei and well-maintained liver architecture. (B) Hepatotoxic control showing highly proliferating small
hepatocytes, eosinophilic cytoplasm with indistinct cell boundaries, and well-maintained liver architecture with increased
vascularity. (C) Petroleum-ether-extract-treated test showing changes in hepatocytes with more  increase in size, coarse
granularity, indistinct cell boundaries, and increased intercellular space. (D) Chloroform-treated test showing changes in
hepatocytes with less increase in size, hyperplasia of Kupffer’s cell, well-maintained liver architecture, and increase in
interstitial cell and vascularity. (E) Acetone-extract-treated test showing disturbed liver architecture, shrunken hepatocytes
with small nuclei, cytoplasm with hyaline changes in a few places, and decreased vascularity. (F) Ethanol-extract-treated
test showing more  prominent hepatocytes with smaller vesicular nuclei, eosinophilic cytoplasm with indistinct cell
boundaries, and disturbed liver architecture with increased vascularity. (G) Silymarin-treated standard showing normal
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ormal control group. Treatment with 400 mg/kg po PEE, CE,
E, and EE in Groups III, IV, V, and VI, respectively, reduced rel-
tive liver weight to 5.43 ± 0.06/100 g (p > 0.05), 5.03 ± 0.05/100 g
p < 0.05), 4.14 ± 0.32/100 g (p < 0.01), and 3.09 ± 0.18/100 g (p
 0.01), respectively, as compared to the hepatotoxic control
roup.  EE-treated Group VI hepatoprotective activity was less
han the standard silymarin-treated Group VII rats at the con-
entration used.
The effects of different extracts of S. pinnata bark on
ifferent liver speciﬁc variables in control and experimental
roups of animals are presented in Table 1. Treatment with
2 ml/kg po 50% ethanol in Group II rats showed signiﬁ-
antly (p < 0.01) increased serum AST (338.68 ± 8.35 mU/mL),
LT (193.53 ± 4.62 mU/mL), ALP (209.58 ± 4.33 mU/mL), LDH
709.58 ± 5.52 mU/mL), cholesterol (0.7921 ± 0.0131 mg/mL),
nd bilirubin (0.028 ± 0.0008 mg/mL) but decreased serum
lbumin (0.028 ± 0.0008 mg/mL) as compared to normal con-
rol Group I rats (89.91 ± 3.21 mU/mL, 39.56 ± 0.64 mU/mL,itecture, and normal interstitial cells.
75.99 ± 1.95 mU/mL, 381.14 ± 3.37 mU/mL, 0.34 ± 0.01 mg/mL,
0.006 ± 0.0002 mg/mL, and 40.7 ± 0.1 mg/mL, respectively).
Treatment with 400 mg/kg po AE in Group V rats signiﬁ-
cantly (p < 0.05) reduced the above to (275.1 ± 12.10 mU/mL,
172.21 ± 8.86 mU/mL, 181.37 ± 9.96 mU/mL, 655.22 ± 29.89
mU/mL, 0.70 ± 0.03 mg/mL, and 0.0253 ± 0.0006 mg/mL) and
increased albumin to 29.6 ± 0.6 mg/mL  as compared to
the hepatotoxic Group II rats. Treatment with 400 mg/kg
po EE in Group VI rats signiﬁcantly (p < 0.01) reduced
the above to (123.55 ± 2.49 mU/mL, 55.92 ± 1.39 mU/mL,
90.04 ± 2.64 mU/mL, 405.26 ± 4.95 mU/mL, 0.41 ± 0.01 mg/mL,
and 0.0087 ± 0.0004 mg/mL) but increased albumin to
43.9 ± 0.1 mg/mL  as compared to the hepatotoxic Group
II rats.
Normal controls had uniform hepatocytes with small vesic-
ular nuclei and well-maintained liver architecture, while
hepatotoxic controls had proliferating small hepatocytes,
eosinophilic cytoplasm with indistinct cell boundaries, and
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Fig. 2 – Gel electrophoretic pattern of DNA isolated from
liver tissues of different groups for the effects of treatment
of the extracts on DNA fragmentation of hepatic tissues in
rats fed with 50% ethanol for 8 consecutive days.
AE, acetone-extract-treated test; CE,
chloroform-extract-treated test; EE, ethanol-extract-treated
test; NC, normal control; PEE,
petroleum-ether-extract-treated test; S, silymarin-treated
standard; TC, toxic control.
well-maintained liver architecture with increased vascularity
(Fig. 1). The EE-treated rats (Group VI) had more  prominent
hepatocytes with smaller vesicular nuclei, eosinophilic cyto-
plasm with indistinct cell boundaries, and well-maintained
liver architecture with increased vascularity. Thus, EE
treatment prevented hepatotoxicity and this activity was com-
parable to the standard drug silymarin.
3.4.  DNA  fragmentation  analysis  of  hepatic  tissues  by
gel electrophoresis
DNA fragmentation detected by electrophoresis as a DNA lad-
der representing a series of fragments (Fig. 2) showed a marked
increase in the toxic control group compared to the normal
control group and treated groups. Treatment with the extracts
resulted in a marked improvement in DNA fragmentation
compared to the toxic control group, suggesting the hepato-
protective action of the different fractions of S. pinnata.
4.  DiscussionThe extractive values in different solvents indicated the quan-
tity and nature of the constituents in each extract. The alcoholIntegr Med Res ( 2 0 1 6 ) 267–275
soluble extractive value was found to be 17.2% w/w,  indicating
the presence of polar constituents like steroids, phenols, alka-
loids, ﬂavonoids, and glycosides, and signifying that a large
amount of constituents of the S. pinnata bark was soluble in
alcohol.23,24
Acute toxicity study of the Spondias mangifera (S. pinnata)
by the ﬁxed-dose method of OECD (Organization for Economic
Co-operation and Development) guideline number 420 did not
exhibit any sign of toxicity up to 2,000 mg/kg.25 Hence, an opti-
mum dose of 400 mg/kg of S. pinnata bark extracts was selected
here for the experimental study.
Alcohol was recognized as a direct hepatotoxin in the
1960s.1 Thus, 12 mL/kg po of 50% ethanol each day for
8 consecutive days was used to induce hepatotoxicity in
rats.16 It is clear from the present study that the 12 ml/kg
po of 50% ethanol (hepatotoxic control) signiﬁcantly (p <
0.01) decreased the levels of antioxidant enzymes, namely,
hepatic GSH, catalase, and SOD and increased the lev-
els of hepatic MDA as compared to the normal control
group rats, leading to oxidative stress. Ethanol consump-
tion leads to the production of excessive reactive oxygen
species, because ethanol is extensively metabolized by the
microsomal oxidizing system to acetaldehyde and then to
acetate by cytochrome P450.26 These reactive oxygen species
oxidize cellular molecules, such as protein and DNA,  and
initiate membrane peroxidative degeneration in the adi-
pose tissue, resulting in fatty inﬁltration of hepatocytes and
causing impairment of gluconeogenesis and diversion of
metabolism to ketogenesis and fatty acid synthesis.26,27 Sim-
ilarly, 12 mL/kg po of 50% ethanol signiﬁcantly (p < 0.01)
decreased the ﬁnal body weight and serum albumin, and sig-
niﬁcantly (p < 0.01) increased the relative liver weight, serum
AST, ALT, ALP, LDH, cholesterol, and bilirubin as in hepa-
totoxic control Group II compared to normal control Group
I rats.
Treatment with 400 mg/kg po AE and EE normalized the dif-
ferent liver-speciﬁc variables altered by 12 mL/kg po ethanol.
Results of the liver function tests were well supported by the
histopathological changes in liver tissues, and the activity
was comparable to the standard drug silymarin. The hep-
atotoxic control Group II showed marked fragmentation of
hepatic DNA while treatment with the extracts resulted in
marked improvement in DNA fragmentation compared to the
toxic control group, suggesting the hepatoprotective action
of the different fractions of S. pinnata. EE (Group VI) showed
greater activity that was comparable with normal control and
silymarin-treated groups.
The hepatoprotection induced by the extracts may be
due to antioxidant property of the extract or phytochemicals
present in the extracts, like ﬂavonoids and polyphenols, which
reduce the oxidative stress imposed by alcohol, and others,
like anti-inﬂammatory and analgesic properties, preventing
inﬂammatory damage.4,25,26,28
From the results of the study, it can be concluded that
the S. pinnata protected Wistar rats from hepatotoxicity via
prevention of ethanol-induced oxidative stress, DNA-damage,
and altered biochemical markers. Thus, this may provide a
novel potent hepatoprotective agent for liver injury, which
could be considered for further clinical studies for future drug
development.
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